5001242025-09-112025-09-115001242025-09-115001242025-09-112025-09-11PartiesOfTheAgreementDomain15001242025-09-11PartiesOfTheAgreementDomain1xbrli:pureDr. Reddy's Laboratories LimitedDRREDDYNewOthersAsset Purchase AgreementExecution of agreementListed Entityfalse2025-09-1023:09:00true2025-09-11Dr. Reddy’s Laboratories Limited (Dr. Reddy’s) has entered into a definitive agreement with Janssen Pharmaceutica NV (JPNV) (naamloze vennootschap), an affiliate of Johnson & Johnson, to acquire the TUGERON® brand, including its leading local brands, Stugeron® FORTE and Stugeron® PLUS as well as its related assets (hereinafter referred to as ‘STUGERON® portfolio’) across 18 markets in the Asia-Pacific (APAC) and Europe, Middle East, and Africa (EMEA) regions, with India and Vietnam as key markets.trueNot Applicable1Janssen Pharmaceutica NVParty entering into the agreementNofalse2025-09-10Through this deal, Dr. Reddy’s has to acquire the STUGERON® brand, including its leading local brands, Stugeron® FORTE and Stugeron® PLUS as well as its related assets (hereinafter referred to as ‘STUGERON® portfolio’) across 18 markets in the Asia-Pacific (APAC) and Europe, Middle East, and Africa (EMEA) regions, with India and Vietnam as key markets.Under the terms of the agreement, Dr. Reddy’s has acquired the STUGERON® portfolio in the aforesaid mentioned markets and the operations will be gradually transitioned to ensure smooth integration of the business.falseNot Applicable